APA (7th ed.) Citation

AV, S., WC, S., A, Y., C, F., H, H., SA, S., . . . J, B. (2026). Cumulative cefepime exposure in cancer patients is associated with an increased risk of ertapenem non-susceptible, meropenem susceptible Enterobacterales bacteremia. Microbiology spectrum, 14(4), e0278125. https://doi.org/10.1128/spectrum.02781-25

Chicago Style (17th ed.) Citation

AV, Stabler, Shropshire WC, Young A, Feng C, Hwang H, Shelburne SA, Vuong NN, and Borjan J. "Cumulative Cefepime Exposure in Cancer Patients Is Associated with an Increased Risk of Ertapenem Non-susceptible, Meropenem Susceptible Enterobacterales Bacteremia." Microbiology Spectrum 14, no. 4 (2026): e0278125. https://doi.org/10.1128/spectrum.02781-25.

MLA (9th ed.) Citation

AV, Stabler, et al. "Cumulative Cefepime Exposure in Cancer Patients Is Associated with an Increased Risk of Ertapenem Non-susceptible, Meropenem Susceptible Enterobacterales Bacteremia." Microbiology Spectrum, vol. 14, no. 4, 2026, p. e0278125, https://doi.org/10.1128/spectrum.02781-25.